Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2336780 | 0.78 | TRPV4 (0.33) | TRPV4 | |
| SCHEMBL9793646 | 0.76 | CYP1A1 (0.34) | TRPV4 | |
| SCHEMBL13636536 | 0.75 | AKR1C3 (0.35) | — | |
| SCHEMBL13636627 | 0.74 | CYP11B1 (0.34) | NFE2L2 | |
| SCHEMBL13952767 | 0.74 | PYCR1 (0.34) | TRPV4 | |
| SCHEMBL31308688 | 0.74 | TSHR (0.35) | TRPV4 | |
| SCHEMBL18297701 | 0.74 | TAAR1 (0.39) | TRPV4 | |
| SCHEMBL80375 | 0.74 | TRPV4 (0.58) | TRPV4 | |
| SCHEMBL18297598 | 0.74 | TRPV4 (0.31) | TRPV4 | |
| SCHEMBL566436 | 0.74 | SELL (0.32) | SELLSELPSELERAPGEF4NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722156-B2 | Liquid crystal compound and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-05-13 | — | — | US | disclosed |
| US-8722156-B2 | Liquid crystal compound and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-05-13 | — | — | US | disclosed |
| US-20130235320-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-09-12 | — | — | US | disclosed |
| US-20130235320-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-09-12 | — | — | US | disclosed |
| US-8486497-B2 | Liquid crystal compound, and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-07-16 | — | — | US | disclosed |
| US-20130100394-A1 | LIQUID CRYSTAL COMPOUND, AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-04-25 | — | — | US | disclosed |
| EP-1813980-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND ELECTRONIC DEVICE HAVING THE SAME | Sharp Kabushiki Kaisha (JP) | 2007-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130100394-A1 | LIQUID CRYSTAL COMPOUND, AND LIQUID CRYSTAL DISPLAY | CCR3, C1S, CNOT1 | SELL 2766/4885SELP 4639/4885SELE 4500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.